Articles

Bayer: creating fertile ground for new digital ideas

4th May 2016

Bayer: creating fertile ground for new digital ideas

Bayer's head of digital development, Jessica Federer, says the company is transforming its business and relationships through digital initiatives – but won't lose sight of its core expertise. Andrew McConaghie... Read more

Modernising strategies for monitoring clinical trials

3rd May 2016

Modernising strategies for monitoring clinical trialsBrett Wilson

Updating monitoring strategies and combining them with the latest technology can streamline clinical trial processes to generate higher quality data and increase patient safety, says Brett Wilson. Brett Wilson   Across the industry... Read more

Digital healthcare round-up: digital uptake, machine learning, Nokia j…

29th April 2016

Digital healthcare round-up: digital uptake, machine learning, Nokia joins medtech boom and moreMarco Ricci

A round-up of this week's top digital healthcare news. Marco Ricci reports. Doubts fuelling a lack of excellence in digital healthcare?There is no doubt that digital is the way forward for... Read more

Healthcare systems aren’t making the most of biosimilars – pharma need…

28th April 2016

Healthcare systems aren’t making the most of biosimilars – pharma needs to support themRichard Staines

Biosimilars could save European and US healthcare systems billions - but more needs to be done to maximise their benefits, writes Richard Staines. Richard StainesBiosimilars are becoming an ever-greater part of... Read more

News

Biogen to spin off haemophilia business

4th May 2016

Biogen to spin off haemophilia businessRichard Staines

Biogen is to spin off its haemophilia business, arguing that splitting the company in two will accelerate progress in the specialist fields of neurology and blood disorders.The growth of Biogen's... Read more

Google's DeepMind given access to NHS patient records

4th May 2016

Google's DeepMind given access to NHS patient recordsMarco Ricci

Google's AI division DeepMind has been granted access to an estimated 1.6 million NHS patient records to help it develop an app for acute kidney injury (AKI).A data-sharing agreement between... Read more

Servier's Lonsurf approved in advanced colorectal cancer in EU

4th May 2016

Servier's Lonsurf approved in advanced colorectal cancer in EURichard Staines

Servier's Lonsurf (trifluridine+tipiracil) has been approved in Europe for adults with metastatic colorectal cancer (mCRC), as the company seeks to increase its presence in oncology medicine.The oral drug came to... Read more

Alnylam gears up for first RNAi therapeutic filing in 2017

4th May 2016

Alnylam gears up for first RNAi therapeutic filing in 2017Andrew McConaghie

US biotech Alnylam says it could file its first product in 2017, a rare disease drug using what has long promised to be a revolutionary approach, RNA interference.The company is... Read more

Audio & Video

Available on demand: Disrupting and impr…

Zephyr 28 April webinar holding slide v2.4

 

There are clear benefits for both Life Sciences companies and their customers in significantly improving the way they... View more

Available on demand – The Creative Debat…

Holding slide Lions Health 11Apr

 

Meeting the needs of both patients, and healthcare professionals, in today's fast changing communications landscape can be challenging, particularly against... View more

Live Q&A panel debate: What does ‘th…

Apr Holding slide Equinix QA debate 08.04.16

 

It is likely that you interact with 'the cloud' on various devices, multiple times throughout the day. However,... View more

Available on demand: Patient centricity …

SDL-Banner-NEW 

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And... View more

White Papers

An integrated digital ecosystem to suppo…

An integrated digital ecosystem to support patient outcomes, health-system sustainability, and return on investment

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world. These heightened... View info

Navigating your way to insights driven c…

Navigating your way to insights driven customer relationships

The Life Sciences industry is under increasing pressure on numerous fronts, and the efficiency and efficacy of the sales process continues to be a focus for improvements.

Customer Relationship... View info

Inspiration: a report highlighting IPF

Inspiration: a report highlighting IPF

Marking Rare Disease Day this week, Boehringer Ingelheim UK’s report Inspiration is a collaboration between patients, patient groups and leading clinicians with the aim of putting IPF in the spotlight... View info

Patient centricity: How does Boehringer …

Patient centricity: How does Boehringer Ingelheim UK measure up?Alan Sumner

Patient centricity is a subject that is massively talked about but few can 'walk the talk'. Fewer still can demonstrate what that walk has achieved and where it is headed.

In 2015 Boehringer Ingelheim UK... View info

Further News & Articles

Pfizer boosted by strong Q1 and possible cancer blockbuster

After the bruising encounter with US tax authorities that ended its $160 billion merger with Allergan last mo... Read more

News

BERG using AI in pancreatic cancer research

Massachusetts-based biopharma company BERG has begun a phase 2 trial for a new pancreatic cancer treatment with ... Read more

News

NICE fast-tracks Novartis' skin cancer combination

NICE has recommended Novartis' combination of Tafinlar and Mekinist for adults with the most serious for... Read more

News

France to push for G7 drug price regulation

France's president Francois Hollande plans to push for international drug price regulation at the 2016 G7 Summit... Read more

News

J&J to appeal against US talc powder cancer ruling

Johnson & Johnson is to appeal against a US court decision that it should pay $55 million to a woman who ... Read more

News

Drug for Parkinson's-related psychosis approved in US

The first drug to treat the common problem of hallucinations and delusions caused by Parkinson's disease, has be... Read more

News

It is impossible to seduce or a delicious dinner, no new postures, and you do not have the patience to put up with having sex once a week? Try Generic Cialis - Often it happens that because of their age or for other reasons, men lose their potency, and against the background of everyday affairs, interest in his personal life is gradually fading. The disease is or penalty for excessive activity at a young age, it's up to you! With Generic Viagra treatment you will keep your potency at the highest level!